Cystic Fibrosis Foundation
North America, Maryland, United States, Bethesda
Description
Cystic Fibrosis Foundation is the world’s leader in the search for a cure for cystic fibrosis.
Investor Profile
Cystic Fibrosis Foundation has backed more than 17 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 18% of its total and boasts 18 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 2 rounds in the past year.
Stage Focus
- Post Ipo Equity (24%)
- Series C (18%)
- Series B (18%)
- Series A (12%)
- Series Unknown (12%)
- Grant (6%)
- Convertible Note (6%)
- Undisclosed (6%)
Country Focus
- United States (53%)
- Israel (24%)
- United Kingdom (18%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (6%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Genetics
- Medical
- Health Diagnostics
- Medical Device
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
